» Articles » PMID: 29039602

LncRNA-MIAT Regulates Cell Biological Behaviors in Gastric Cancer Through a Mechanism Involving the MiR-29a-3p/HDAC4 Axis

Overview
Journal Oncol Rep
Specialty Oncology
Date 2017 Oct 18
PMID 29039602
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric cancer (GC) is one of the most common malignant diseases worldwide. Although significant progress has been made in the early detection and treatment of GC over the past decades, the prognosis is still not satisfactory and the underlying mechanisms of carcinogenesis remain unknown. Long non-coding RNA MIAT has been established as a key player in the regulation of various biological and pathological processes including chronic lymphocytic leukemias, acute myocardial infarction and neuroendocrine prostate cancer. However, the function of MIAT in GC remains largely unknown. The expressions of lncRNA MIAT, miR-29a-3p and HDAC4 mRNA were analysed using quantitative real-time PCR (qRT-PCR). RNA interference approach was used to investigate the cellular functions of MIAT and miR-29a-3p. Cell Counting Kit-8 (CCK-8) assay and flow cytometry assay were performed to detect cell proliferation and apoptosis. Cell migration and invasion abilities were evaluated by Transwell assays. In the present study, we first confirmed the high expression level of MIAT in GC tissues and cell lines. In addition, knockdown of MIAT suppressed the proliferation, migration and invasion of GC cells in vitro. Furthermore, our results demonstrated that MIAT competitively binds to miR-29a-3p and consequently upregulates the expression of HDAC4, which is a downstream target of miR-29a-3p. In conclusion, the present study highlighted the involvement of the MIAT/miR-29a-3p/HDAC4 axis in the development of GC, which provided potential diagnostic and therapeutic targets for GC.

Citing Articles

Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model.

Chuang T, Ton N, Manrique N, Rysling S, Khorram O Clin Sci (Lond). 2024; 138(12):699-709.

PMID: 38817011 PMC: 11166562. DOI: 10.1042/CS20240190.


A Comprehensive Understanding of Post-Translational Modification of Sox2 via Acetylation and -GlcNAcylation in Colorectal Cancer.

Seo Y, Kim D, Park J, Park S, Park J, Cheon J Cancers (Basel). 2024; 16(5).

PMID: 38473392 PMC: 10931190. DOI: 10.3390/cancers16051035.


Long non-coding RNAs as potential biomarkers or therapeutic targets in gastric cancer.

Askari N, Salek Esfahani B, Parvizpour S, Shafieipour S, Hadizadeh M Gastroenterol Hepatol Bed Bench. 2023; 16(3):297-306.

PMID: 37767321 PMC: 10520387. DOI: 10.22037/ghfbb.v16i2.2701.


Bioinformatics and pathway enrichment analysis identified hub genes and potential biomarker for gastric cancer prognosis.

Darang E, Pezeshkian Z, Mirhoseini S, Ghovvati S Front Oncol. 2023; 13:1187521.

PMID: 37361568 PMC: 10288990. DOI: 10.3389/fonc.2023.1187521.


LncRNA MIAT Upregulates NEGR1 by Competing for miR-150-5p as a Competitive Endogenous RNA in SCIRI Rats.

Wang Z, Liu J, Yang Q, Ma M Int J Genomics. 2023; 2022:2942633.

PMID: 36620092 PMC: 9812626. DOI: 10.1155/2022/2942633.